| Year |
Citation |
Score |
| 2013 |
Loram LC, Taylor FR, Strand KA, Harrison JA, Rzasalynn R, Sholar P, Rieger J, Maier SF, Watkins LR. Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling. Brain, Behavior, and Immunity. 33: 112-22. PMID 23811314 DOI: 10.1016/j.bbi.2013.06.004 |
0.336 |
|
| 2013 |
Voloshyna I, Carsons S, Littlefield MJ, Rieger JM, Figler R, Reiss AB. Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells. Biochimica Et Biophysica Acta. 1831: 407-16. PMID 23168167 DOI: 10.1016/j.bbalip.2012.11.005 |
0.381 |
|
| 2012 |
Li Y, Figler RA, Kolling G, Bracken TC, Rieger J, Stevenson RW, Linden J, Guerrant RL, Warren CA. Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment. Bmc Infectious Diseases. 12: 342. PMID 23217055 DOI: 10.1186/1471-2334-12-342 |
0.344 |
|
| 2012 |
Warren CA, Calabrese GM, Li Y, Pawlowski SW, Figler RA, Rieger J, Ernst PB, Linden J, Guerrant RL. Effects of adenosine Aâ‚‚A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice. Bmc Infectious Diseases. 12: 13. PMID 22264229 DOI: 10.1186/1471-2334-12-13 |
0.435 |
|
| 2009 |
Loram LC, Harrison JA, Sloane EM, Hutchinson MR, Sholar P, Taylor FR, Berkelhammer D, Coats BD, Poole S, Milligan ED, Maier SF, Rieger J, Watkins LR. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 14015-25. PMID 19890011 DOI: 10.1523/Jneurosci.3447-09.2009 |
0.353 |
|
| 2009 |
Wilson JM, Ross WG, Agbai ON, Frazier R, Figler RA, Rieger J, Linden J, Ernst PB. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 4616-23. PMID 19342636 DOI: 10.4049/Jimmunol.0801279 |
0.414 |
|
| 2009 |
Alam MS, Kurtz CC, Wilson JM, Burnette BR, Wiznerowicz EB, Ross WG, Rieger JM, Figler RA, Linden J, Crowe SE, Ernst PB. A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence. Mucosal Immunology. 2: 232-42. PMID 19262506 DOI: 10.1038/Mi.2009.4 |
0.457 |
|
| 2009 |
Loram L, Sholar P, Taylor F, Harrison J, Hutchinson M, Maier S, Rieger J, Watkins L, Sloane E. Adenosine 2A receptor agonist produces long-duration reversal of neuropathic pain via sustained release of spinal interleukin-10 The Journal of Pain. 10: S39. DOI: 10.1016/J.Jpain.2009.01.165 |
0.343 |
|
| 2007 |
Glover DK, Ruiz M, Takehana K, Petruzella FD, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. American Journal of Physiology. Heart and Circulatory Physiology. 292: H3164-71. PMID 17308004 DOI: 10.1152/Ajpheart.00743.2005 |
0.662 |
|
| 2006 |
Li Y, Oskouian RJ, Day YJ, Rieger JM, Liu L, Kern JA, Linden J. Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells. Neuroscience. 141: 2029-39. PMID 16777350 DOI: 10.1016/J.Neuroscience.2006.05.014 |
0.464 |
|
| 2006 |
Cavalcante IC, Castro MV, Barreto AR, Sullivan GW, Vale M, Almeida PR, Linden J, Rieger JM, Cunha FQ, Guerrant RL, Ribeiro RA, Brito GA. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infection and Immunity. 74: 2606-12. PMID 16622196 DOI: 10.1128/Iai.74.5.2606-2612.2006 |
0.444 |
|
| 2005 |
Day YJ, Li Y, Rieger JM, Ramos SI, Okusa MD, Linden J. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. Journal of Immunology (Baltimore, Md. : 1950). 174: 5040-6. PMID 15814735 DOI: 10.4049/Jimmunol.174.8.5040 |
0.447 |
|
| 2005 |
Lappas CM, Rieger JM, Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 1073-80. PMID 15634932 DOI: 10.4049/Jimmunol.174.2.1073 |
0.458 |
|
| 2005 |
Glover DK, Riou LM, Ruiz M, Sullivan GW, Linden J, Rieger JM, Macdonald TL, Watson DD, Beller GA. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. American Journal of Physiology. Heart and Circulatory Physiology. 288: H1851-8. PMID 15591104 DOI: 10.1152/Ajpheart.00362.2004 |
0.637 |
|
| 2003 |
Haji-Momenian S, Rieger JM, Macdonald TL, Brown ML. Comparative molecular field analysis and QSAR on substrates binding to cytochrome p450 2D6. Bioorganic & Medicinal Chemistry. 11: 5545-54. PMID 14642599 DOI: 10.1016/S0968-0896(03)00525-X |
0.506 |
|
| 2002 |
Riou LM, Ruiz M, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA, Glover DK. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A2A-receptor-mediated coronary vasodilation Journal of the American College of Cardiology. 40: 1687-1694. PMID 12427424 DOI: 10.1016/S0735-1097(02)02372-0 |
0.637 |
|
| 2002 |
Fiser SM, Tribble CG, Kaza AK, Long SM, Kern JA, Cassada DC, Linden J, Rieger J, Laubach VE, Matisoff A, Kron IL. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. The Journal of Thoracic and Cardiovascular Surgery. 124: 973-8. PMID 12407381 DOI: 10.1067/Mtc.2002.124886 |
0.43 |
|
| 2002 |
Cassada DC, Tribble CG, Long SM, Kaza AK, Linden J, Rieger JM, Rosin D, Kron IL, Kern JA. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons. The Annals of Thoracic Surgery. 74: 846-9; discussion 84. PMID 12238849 DOI: 10.1016/S0003-4975(02)03793-1 |
0.403 |
|
| 2002 |
Cassada DC, Tribble CG, Long SM, Laubach VE, Kaza AK, Linden J, Nguyen BN, Rieger JM, Fiser SM, Kron IL, Kern JA. Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. Journal of Vascular Surgery. 35: 994-8. PMID 12021717 DOI: 10.1067/Mva.2002.123091 |
0.326 |
|
| 2002 |
Murphree LJ, Marshall MA, Rieger JM, MacDonald TL, Linden J. Human A2A adenosine receptors: High-affinity agonist binding to receptor-g protein complexes containing Gβ4 Molecular Pharmacology. 61: 455-462. PMID 11809871 DOI: 10.1124/Mol.61.2.455 |
0.636 |
|
| 2002 |
Riou LM, Ruiz M, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA, Glover DK. Verapamil attenuates the coronary vasodilatory response to adenosine and A 2A adenosine receptor agonists Journal of the American College of Cardiology. 39: 369. DOI: 10.1016/S0735-1097(02)81660-6 |
0.645 |
|
| 2001 |
Cassada DC, Gangemi JJ, Rieger JM, Linden J, Kaza AK, Long SM, Kron IL, Tribble CG, Kern JA. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. The Annals of Thoracic Surgery. 72: 1245-50. PMID 11603444 DOI: 10.1016/S0003-4975(01)03057-0 |
0.359 |
|
| 2001 |
Glover DK, Ruiz M, Takehana K, Petruzella FD, Riou LM, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA. Pharmacological stress myocardial perfusion imaging with the potent and selective A2A adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection Circulation. 104: 1181-1187. PMID 11535577 DOI: 10.1161/Hc3601.093983 |
0.643 |
|
| 2001 |
Cassada DC, Tribble CG, Laubach VE, Nguyen BN, Rieger JM, Linden J, Kaza AK, Long SM, Kron IL, Kern JA. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. Journal of Vascular Surgery. 34: 482-8. PMID 11533601 DOI: 10.1067/Mva.2001.117996 |
0.398 |
|
| 2001 |
Cassada DC, Tribble CG, Kaza AK, Fiser SM, Long SM, Linden J, Rieger JM, Kron IL, Kern JA. Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion. Surgery. 130: 230-5. PMID 11490354 DOI: 10.1067/Msy.2001.115838 |
0.383 |
|
| 2001 |
Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J. Selective A2A adenosine receptor activation reduces skin pressure ulcer formation and inflammation American Journal of Physiology - Heart and Circulatory Physiology. 281: H67-H74. PMID 11406470 DOI: 10.1152/Ajpheart.2001.281.1.H67 |
0.602 |
|
| 2001 |
McPherson JA, Barringhaus KG, Bishop GG, Sanders JM, Rieger JM, Hesselbacher SE, Gimple LW, Powers ER, Macdonald T, Sullivan G, Linden J, Sarembock IJ. Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arteriosclerosis, Thrombosis, and Vascular Biology. 21: 791-6. PMID 11348876 DOI: 10.1161/01.Atv.21.5.791 |
0.647 |
|
| 2001 |
Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. British Journal of Pharmacology. 132: 1017-26. PMID 11226132 DOI: 10.1038/Sj.Bjp.0703893 |
0.635 |
|
| 2001 |
Rieger JM, Brown ML, Sullivan GW, Linden J, Macdonald TL. Design, synthesis, and evaluation of novel A2A adenosine receptor agonists Journal of Medicinal Chemistry. 44: 531-539. PMID 11170643 DOI: 10.1021/Jm0003642 |
0.613 |
|
| 2000 |
Okusa MD, Linden J, Huang L, Rieger JM, MacDonald TL, Huynh LP. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion American Journal of Physiology - Renal Physiology. 279: F809-F818. PMID 11053040 DOI: 10.1152/Ajprenal.2000.279.5.F809 |
0.636 |
|
| 2000 |
Brown ML, Rieger JM, Macdonald TL. Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on beta-tubulin. Bioorganic & Medicinal Chemistry. 8: 1433-41. PMID 10896120 DOI: 10.1016/S0968-0896(00)00068-7 |
0.527 |
|
| Show low-probability matches. |